|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||4.31 - 4.69|
|52 Week Range||1.92 - 9.74|
|Beta (3Y Monthly)||10.85|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Keith Bliss of Cuttone and Company joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss Canopy Growth Corp (CGC), which begins trading on NYSE today and is the first pure cannabis play to achieve a listing on the exchange.
It's official, recreational pot is now legal in California. Yahoo Finance's Seana Smith, Rick Newman, and Justine Underhill discuss how weed policy will affect the golden state.
MESQUITE, NV / ACCESSWIRE / October 25, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that on October 23, 2018, the United States Patent Office issued US Patent number 10105343 titled “Cannabis based compositions and methods of treating hypertension” to Cannabis Sativa”. The marijuana lozenge invention relates to a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery comprising a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plant Cannabis sativa, subspecies sativa and Cannabis sativa, subspecies indica of the CTSX-ISS lineage. “CBDS acquired the rights to certain pending IP in a stock based, multimillion dollar agreement in 2014”, said President David Tobias.
Marijuana stocks, fueled by what may well be the biggest legal and medical revolution in years, have already proven they’re blazing their own trail. In all cases, though, there’s explosive potential on the table — the legal marijuana industry’s story has just gotten that compelling, as more states seek to legalize it while regulators finally start to see its legitimate medical benefits. Of all the marijuana stocks worth a look right now, Canopy Growth (NYSE:CGC) has garnered the most attention of late.
MESQUITE, NV / ACCESSWIRE / October 15, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that the United States Patent Office will issue to CBDS the US Patent number 10105343 titled "Cannabis based compositions and methods of treating hypertension" on October 23, 2018. "Cannabis Sativa made a bold deal acquiring this pending IP in the merger acquisition of Kush in 2014, which included Kubby Patent and Licenses. "This coconut oil based lozenge is unique because of its rapid onset and long term effects, and is based on our patented strain of cannabis, Ecuadorian Sativa", stated President David Tobias.
Investors are clamoring for ways to get in on a popular, but risky, marijuana investing craze. Despite the reality that pot is illegal under federal law, many states have legalized the substance and plenty of marijuana ETFs have cropped up as a result.
MESQUITE, NV / ACCESSWIRE / September 25, 2018 / Cannabis Sativa, Inc. (CBDS) subsidiary PrestoDoctor is pleased to announce that it is currently providing online medical marijuana recommendations to Pennsylvania residents via its HIPPA compliant trusted online recommendation platform https://Prestodoctor.Com/. PrestoDoctor makes the process simple and seamless by providing the state required two doctor appointments completely online, allowing patients to speak to licensed compassionate physicians who specialize in medical marijuana evaluations. Post appointment, PrestoDoctor provides patients all the necessary instructions on registering with the state in a comprehensive email.
NEW YORK, NY / ACCESSWIRE / September 18, 2018 / U.S. equities retreated from records Monday as President Donald Trump plans to announce an additional $200 billion in tariffs on Chinese products. The Dow ...
Tilray (NASDAQ:TLRY) has made some lucky investors much, much richer than they were just a few weeks ago. Tilray stock is now up more than 500% from its July 19 IPO price, and up more than 350% for traders who bought it on the open market immediately following its initial public offering.
MESQUITE, NV / ACCESSWIRE / September 12, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, tops the High Times list of their first ever 'Women in Weed'' themed issue. Debby Goldsberry was lauded as an advocate and owner operator of Magnolia Oakland Dispensary. ''We congratulate Debby Goldsberry for her well-deserved top placement,'' said CEO and former Senator Mike Gravel, ''I am proud to have motivated Debby to come aboard Cannabis Sativa.
MESQUITE, NV / ACCESSWIRE / April 5, 2018 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that PrestoDoctor®, the leading online medical marijuana recommendation service, will be expanding ...
This has been a great week for marijuana stocks and cannabis in general. The United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., posted strong gains this week of ...
MESQUITE, NV / ACCESSWIRE / January 16, 2018 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to present the documentary "I Am Gary Johnson" and panel discussion of political influencers January ...
MESQUITE, NV / ACCESSWIRE / December 4, 2017 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that its subsidiary, PrestoDoctor , is expanding its online medical marijuana recommendation services ...
MESQUITE, NV / ACCESSWIRE / November 21, 2017 / Cannabis Sativa, Inc. (OTCQB: CBDS ) is proud to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, has been named in the ...
MESQUITE, NV / ACCESSWIRE / November 15, 2017 / Cannabis Sativa (OTCQB: CBDS) is proud to announce that Kyle Powers, Cofounder of PrestoDoctor, a Cannabis Sativa, Inc. subsidiary, made the Class of 2018 ...